What you'll learn

  • Apply knowledge of recent clinical data together with current expert recommendations to patient selection for new and emerging therapies for advanced breast cancer
  • Apply knowledge in the treatment of breast cancer in special populations (including the elderly and young women) and adjust treatment decisions for specific patients as needed
  • Select appropriate risk assessment modalities, where applicable, and make evidence-based therapeutic selections for women who are candidates for neoadjuvant or adjuvant therapy and know the limitations of genomic testing
  • Apply recent clinical data and expert recommendations to the management of women with breast cancer who are treated with mastectomy, including integration of surgical methods, breast reconstruction options, and post-mastectomy radiation if needed
  • Assess current practices with regard to symptom management during active treatment and in survivorship and consider the needs for fertility and lifestyle counseling among patients with breast cancer and survivors, and improve current practices if needed
  • Evaluate the genetic and personal risk factors of breast cancer and utilize appropriate genetic testing for hereditary breast cancer

Course description

This is an accredited, livestreamed course offered by Dana Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital. This course is targeted to Primary Care Physicians, Specialty Physicians, Nurses, Nurse Practitioners,and Physician Assistants. This course may also be of interest to physicians who practice in Oncology and Hematology, Plastic Surgery, Surgery, Internal Medicine, Genetics, and Family Medicine.

Select the Take Course button to view additional information on the course registration page.

Contact ceprograms@hms.harvard.edu with questions.

*Register before June 1 to receive the discounted price.

Enroll now.
Learn More